Generali Asset Management SPA SGR

Source: SEC Form 13F · as of Mar 2026

Generali Asset Management SPA SGR holds 32 biotech & pharma companies tracked by BioSniper, totaling $379.3M in value as of Mar 2026 (SEC Form 13F).

Companies held

32

Total value held

$379.3M

CompanySharesValue
AZNASTRAZENECA PLC954,783$140.3M
LLYELI LILLY & Co62,651$57.6M
MRKMerck & Co., Inc.284,084$34.2M
AMGNAMGEN INC50,205$17.7M
ABBVAbbVie Inc.80,486$17.5M
BMYBRISTOL MYERS SQUIBB CO252,642$15.3M
ABTABBOTT LABORATORIES95,003$9.8M
GMOptec International, Inc.109,736$8.2M
VRTXVERTEX PHARMACEUTICALS INC / MA15,300$6.8M
BIIBBIOGEN INC.34,194$6.3M
ZTSZoetis Inc.52,334$6.2M
CORCencora Inc.18,708$5.9M
REGNREGENERON PHARMACEUTICALS, INC.7,504$5.8M
PFEPFIZER INC206,394$5.8M
ELVElevance Health Inc.18,876$5.5M
PMPhilip Morris International Inc33,076$5.5M
IQVIQVIA Holdings Inc.28,537$4.9M
MCKMcKesson Corporation5,261$4.6M
IDXXIDEXX LABORATORIES INC /DE7,737$4.3M
DGXQuest Diagnostics Incorporated22,078$4.3M
NBIXNEUROCRINE BIOSCIENCES INC25,550$3.4M
UTHRUNITED THERAPEUTICS Corp3,358$2.0M
WSTWest Pharmaceutical Services Inc.7,029$1.8M
QGENQIAGEN N.V.49,680$1.7M
INCYIncyte Corp.17,105$1.6M
ZBHZimmer Biomet Holdings Inc.15,317$1.4M
ALNYALNYLAM PHARMACEUTICALS, INC.3,193$1.1M
CAHCardinal Health Inc.498$105K
RPRXRoyalty Pharma plc429$21K
BAXBaxter International Inc.290$5K
BNTXBioNTech SE7$622
OGNOrganon & Co.25$150

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.

    Generali Asset Management SPA SGR — Biotech 13F Holdings & Portfolio | BioSniper